Header Logo

Connection

SANJAY DESHPANDE to Prognosis

Back to Details
This is a "connection" page, showing publications SANJAY DESHPANDE has written about Prognosis.
SANJAY DESHPANDE
Connection Strength
0.020
Prognosis
  1. Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis. Haematologica. 2019 05; 104(5):e211-e214.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.